708 related articles for article (PubMed ID: 15322537)
1. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.
Petrova TV; Karpanen T; Norrmén C; Mellor R; Tamakoshi T; Finegold D; Ferrell R; Kerjaschki D; Mortimer P; Ylä-Herttuala S; Miura N; Alitalo K
Nat Med; 2004 Sep; 10(9):974-81. PubMed ID: 15322537
[TBL] [Abstract][Full Text] [Related]
2. Comparative lymphatic, ocular, and metabolic phenotypes of Foxc2 haploinsufficient and aP2-FOXC2 transgenic mice.
Noon A; Hunter RJ; Witte MH; Kriederman B; Bernas M; Rennels M; Percy D; Enerbäck S; Erickson RP
Lymphology; 2006 Jun; 39(2):84-94. PubMed ID: 16910099
[TBL] [Abstract][Full Text] [Related]
3. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.
Kriederman BM; Myloyde TL; Witte MH; Dagenais SL; Witte CL; Rennels M; Bernas MJ; Lynch MT; Erickson RP; Caulder MS; Miura N; Jackson D; Brooks BP; Glover TW
Hum Mol Genet; 2003 May; 12(10):1179-85. PubMed ID: 12719382
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
[TBL] [Abstract][Full Text] [Related]
5. Literature watch. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome.
Pepper MS
Lymphat Res Biol; 2003; 1(3):245-9. PubMed ID: 15624441
[No Abstract] [Full Text] [Related]
6. Foxc2 is expressed in developing lymphatic vessels and other tissues associated with lymphedema-distichiasis syndrome.
Dagenais SL; Hartsough RL; Erickson RP; Witte MH; Butler MG; Glover TW
Gene Expr Patterns; 2004 Oct; 4(6):611-9. PubMed ID: 15465483
[TBL] [Abstract][Full Text] [Related]
7. Clinical and genetic study of 46 Italian patients with primary lymphedema.
Michelini S; Degiorgio D; Cestari M; Corda D; Ricci M; Cardone M; Mander A; Famoso L; Contini E; Serrani R; Pinelli L; Cecchin S; Bertelli M
Lymphology; 2012 Mar; 45(1):3-12. PubMed ID: 22768468
[TBL] [Abstract][Full Text] [Related]
8. Lymphedema-distichiasis and FOXC2 gene mutations.
Erickson RP
Lymphology; 2001 Mar; 34(1):1. PubMed ID: 11307659
[No Abstract] [Full Text] [Related]
9. Abnormal mural cell recruitment in lymphatic capillaries: a common pathological feature in chronic lymphedematous skin?
Yu ZY; Sun D; Luo Y; Liu NF
Microcirculation; 2016 Oct; 23(7):495-502. PubMed ID: 27455448
[TBL] [Abstract][Full Text] [Related]
10. H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice.
Ichise T; Yoshida N; Ichise H
Development; 2010 Mar; 137(6):1003-13. PubMed ID: 20179099
[TBL] [Abstract][Full Text] [Related]
11. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
Saito Y; Nakagami H; Morishita R; Takami Y; Kikuchi Y; Hayashi H; Nishikawa T; Tamai K; Azuma N; Sasajima T; Kaneda Y
Circulation; 2006 Sep; 114(11):1177-84. PubMed ID: 16952986
[TBL] [Abstract][Full Text] [Related]
12. Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2.
Liebl J; Zhang S; Moser M; Agalarov Y; Demir CS; Hager B; Bibb JA; Adams RH; Kiefer F; Miura N; Petrova TV; Vollmar AM; Zahler S
Nat Commun; 2015 Jun; 6():7274. PubMed ID: 26027726
[TBL] [Abstract][Full Text] [Related]
13. The establishment of a predictive mutational model of the forkhead domain through the analyses of FOXC2 missense mutations identified in patients with hereditary lymphedema with distichiasis.
Berry FB; Tamimi Y; Carle MV; Lehmann OJ; Walter MA
Hum Mol Genet; 2005 Sep; 14(18):2619-27. PubMed ID: 16081467
[TBL] [Abstract][Full Text] [Related]
14. Lymphedema-distichiasis syndrome: a distinct type of primary lymphedema caused by mutations in the FOXC2 gene.
Vreeburg M; Heitink MV; Damstra RJ; Moog U; van Geel M; van Steensel MA
Int J Dermatol; 2008 Nov; 47 Suppl 1():52-5. PubMed ID: 18986489
[TBL] [Abstract][Full Text] [Related]
15. Combining Foxc2 and Connexin37 deletions in mice leads to severe defects in lymphatic vascular growth and remodeling.
Kanady JD; Munger SJ; Witte MH; Simon AM
Dev Biol; 2015 Sep; 405(1):33-46. PubMed ID: 26079578
[TBL] [Abstract][Full Text] [Related]
16. A system for quantifying the patterning of the lymphatic vasculature.
Shayan R; Karnezis T; Tsantikos E; Williams SP; Runting AS; Ashton MW; Achen MG; Hibbs ML; Stacker SA
Growth Factors; 2007 Dec; 25(6):417-25. PubMed ID: 18365872
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic collecting vessel maturation and valve morphogenesis.
Vittet D
Microvasc Res; 2014 Nov; 96():31-7. PubMed ID: 25020266
[TBL] [Abstract][Full Text] [Related]
18. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb.
Mellor RH; Brice G; Stanton AW; French J; Smith A; Jeffery S; Levick JR; Burnand KG; Mortimer PS;
Circulation; 2007 Apr; 115(14):1912-20. PubMed ID: 17372167
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic endothelial cells, lymphedematous lymphangiogenesis, and molecular control of edema formation.
Ji RC
Lymphat Res Biol; 2008; 6(3-4):123-37. PubMed ID: 19093784
[TBL] [Abstract][Full Text] [Related]
20. Targeted treatment for lymphedema and lymphatic metastasis.
Tervala T; Suominen E; Saaristo A
Ann N Y Acad Sci; 2008; 1131():215-24. PubMed ID: 18519974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
